The Viral Inactivation Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Viral Inactivation Market:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report
According to The Business Research Company’s Viral Inactivation Global Market Report 2024, The viral inactivation market size has grown strongly in recent years. It will grow from $4.54 billion in 2023 to $4.98 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to global air traffic growth, enhanced navigation capabilities, commercial aviation expansion, airline cost savings, improved flight safety, reduction in pilot workload.
The viral inactivation market size is expected to see rapid growth in the next few years. It will grow to $7.32 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to autonomous flight development, next-generation aircraft designs, efforts for sustainable aviation, urban air mobility (uam), increasing demand for aircraft. Major trends in the forecast period include integration of advanced avionics, implementation of artificial intelligence, human-machine interface (hmi) innovations, retrofitting existing aircraft, global navigation satellite system (gnss) integration.
Growing instances of various infectious diseases are expected to propel the growth of the viral inactivation market, going forward. Infectious diseases refer to the conditions that transmit from one individual to another, via polluted foods and beverages, and through pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation is widely applicable in human disease-control programs to inactivate viruses using physical and chemical disinfectants to prevent the spread of contagious viral infections, resulting in the growth of the viral inactivation market. For instance, in December 2022, according to the ‘Annual Epidemiological Report for 2021’, published by European Centre for Disease Prevention and Control, a Sweden-based, European Government Health Agency, 2021, the distribution of hepatitis C cases and rates per 100,000 population, in Germany, reached 4,718 cases and 5.7 rates respectively from 4,536 cases 5.5 rates in 2020. Therefore, the growing instances of various infectious diseases are driving the growth of the viral inactivation market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp
The viral inactivation market covered in this report is segmented –
1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users
The increasing use of technologically advanced processes is a key trend gaining popularity in the viral inactivation market. Companies operating in the viral inactivation market are adopting technologically advanced processes to sustain their position in the market. For instance, in March 2022, WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, a China-based, biopharmaceutical company, launched Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This cutting-edge technology has enabled, the approval of new therapies by conducting all assay formulation, biosafety, viral clearance, product release, and testing, done simultaneously, in-house. This technique is a novel innovative method for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without the need for transfection.
The viral inactivation market report table of contents includes:
1. Executive Summary
2. Viral Inactivation Market Characteristics
3. Viral Inactivation Market Trends And Strategies
4. Viral Inactivation Market - Macro Economic Scenario
5. Global Viral Inactivation Market Size and Growth
..................
31. Global Viral Inactivation Market Competitive Benchmarking
32. Global Viral Inactivation Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Viral Inactivation Market
34. Viral Inactivation Market Future Outlook and Potential Analysis
35. Appendix
Read Related Topics:
https://goodprnews.com/satellite-launch-vehicle-global-market-size/
https://goodprnews.com/scar-treatment-global-market-size/
https://goodprnews.com/secondary-agricultural-nutrients-global-market-size/
https://topprnews.com/satellite-launch-vehicle-global-market-share/
https://topprnews.com/scar-treatment-global-market-share/
https://topprnews.com/secondary-agricultural-nutrients-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
According to the new market research report "Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021", published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global Viral Inactivation Market along with the estimates and forecasts of the revenue and market share analysis.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017The Global Viral Inactivation Market was valued at USD 320.5 Million in 2016.
This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.The global Viral Inactivation Market is segmented on the basis of method, product, application, end user, and geography.
Of these, the solvent detergent method segment accounted for the largest share of the global Viral Inactivation Market in 2015.The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics.
Of these the vaccines and therapeutics application hold the highest share.Browse and in-depth TOC on "Viral Inactivation Market" 72 - Tables70 - Figures 154 - Pages By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.
Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.
Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period (2016-2021).
The Global Viral Inactivation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The report offers a value chain analysis that gives a comprehensive outlook of the market.
The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Viral Inactivation Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/8879-viral-inactivation-market-reportThe report also covers the complete competitive landscape of the global Viral Inactivation market with company profiles of key players such as:Danaher CorporationMerck KGAAParker Hannifin CorporationSartorius AGSGS SACharles River Laboratories International, Inc.Clean Cells Inc.Rad Source Technologies, Inc.Texcell, Inc.Viral Inactivated Plasma Systems SAWuxi Pharmatech (Cayman) Inc.SEGMENTATIONS IN REPORT:By Method:Solvent Detergent MethodPasteurizationOther Viral Inactivation MethodBy Product:Kits and ReagentsServicesViral Inactivation Systems and AccessoriesBy Applications:Blood & Blood ProductsCellular & Gene Therapy ProductsStem Cell ProductsTissue & Tissue ProductsVaccines By End User:Pharmaceutical and Biotechnology CompaniesContract Research OrganizationsAcademic Research InstitutesOther End UsersBy Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global Viral Inactivation Market @ https://www.decisiondatabases.com/contact/download-sample-8879The Global Viral Inactivation Market has been exhibited in detail in the following chapters –Chapter 1 Viral Inactivation Market PrefaceChapter 2 Executive SummaryChapter 3 Viral Inactivation Industry AnalysisChapter 4 Viral Inactivation Market Value Chain AnalysisChapter 5 Viral Inactivation Market Analysis By MethodChapter 6 Viral Inactivation Market Analysis By ProductChapter 7 Viral Inactivation Market Analysis By ApplicationsChapter 8 Viral Inactivation Market Analysis By End-UserChapter 9 Viral Inactivation Market Analysis By GeographyChapter 10 Competitive Landscape Of Viral Inactivation CompaniesChapter 11 Company Profiles Of Viral Inactivation IndustryPurchase the complete Global Viral Inactivation Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-8879Other Reports by DecisionDatabases.com:Global Viral Clearance Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Antiviral Drugs Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Viral Conjunctivitis Pipeline Drugs Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
These methods are commonly utilized in the food and blood plasma sectors, since they can be weakened by the presence of viral particles.Viral inactivation stops viruses from infecting.
In viral inactivation, the surface chemistry of the virus is changed, and in numerous cases, viral particles exist in the finished product.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=81404Key Drivers, Restrains, and Opportunities of Global Viral Inactivation Kit MarketIncrease in the global prevalence of infectious diseases such as cancer, autoimmune disorders, and other diseases along with an increase in healthcare spending are key factors boosting the viral inactivation industry.
For instance, in April 2020, Sartorius extended its portfolio for the growth and manufacture of biotech medicines with the acquisition of Danaher Corporation.Rise in COVID-19 cases is also driving the viral inactivation kit market, as viral inactivation is an important step prior to reducing the bio containment level in laboratory workers who are handling materials that contain SARS-CoV-2.
Governments in developing countries are making significant investments to modernize healthcare infrastructure, which is likely to increase access to health care.
Increase in prevalence of chronic diseases in developing countries offers significant opportunities to the global viral Inactivation kit market.Request COVID Analysis on Viral Inactivation Kit Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=81404 North America to Capture Major Share of Global Viral Inactivation Kit MarketNorth America is estimated to dominate the global market during the forecast period.
Moreover, advanced healthcare facilities, the involvement of large pharmaceutical and biopharmaceutical firms, and substantial spending on health R by governments and companies in the U.S. are key factors that are expected to fuel the industry in North America.Following North America, Europe accounted for the second-highest share of the global viral inactivation kit market due to extensive R spending in the life sciences industry and new product launches in the regionThe market in Asia Pacific is anticipated to expand at a significant pace during the forecast period, due to improvement of healthcare infrastructure in emerging nations and growing awareness-raising initiatives.
The latest trending report Global Viral Inactivation Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Viral Inactivation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 487.1 million by 2025, from USD 376.2 million in 2019.The Viral Inactivation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/20840-viral-inactivation-industry-analysis-reportThe major players covered in Viral Inactivation are:DanaherRad Source TechnologiesSartoriusMerckClean CellsParker HannifinViral Inactivated Plasma SystemsCharles River Laboratories InternationalSGSTexcellWuxi Pharmatech (Cayman)By Type, Viral Inactivation market has been segmented into: Kits and Reagents Services Viral Inactivation Systems and AccessoriesBy Application, Viral Inactivation has been segmented into: Blood and Blood Products Cellular and Gene Therapy Products Stem Cell Products Tissue and Tissue Products Vaccines and TherapeuticsThe report offers in-depth assessment of the growth and other aspects of the Viral Inactivation market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Viral Inactivation Market @ https://www.decisiondatabases.com/contact/download-sample-20840There are 14 Chapters to deeply display the global Viral Inactivation market.1 Viral Inactivation Market Overview2 Company Profiles3 Global Viral Inactivation Market Competition, by Players4 Global Viral Inactivation Market Size by Regions5 North America Viral Inactivation Revenue by Countries6 Europe Viral Inactivation Revenue by Countries7 Asia-Pacific Viral Inactivation Revenue by Countries8 South America Viral Inactivation Revenue by Countries9 Middle East and Africa Revenue Viral Inactivation by Countries10 Global Viral Inactivation Market Segment by Type11 Global Viral Inactivation Market Segment by Application12 Global Viral Inactivation Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global Viral Inactivation Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-20840Other Reports by DecisionDatabases.com:Global Viral Clearance Service Market 2019 by Company, Regions, Type and Application, Forecast to 2024Global Viral Disease Diagnosis Market 2019 by Company, Regions, Type and Application, Forecast to 2024Global Viral Vectors and Plasmid DNA Manufacturing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
The global viral inactivation market size is anticipated to reach USD 5.1 billion by 2025, growing at a CAGR of 12.5%, according to a new report by Grand View Research, Inc. Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth.Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries.
With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front.
Increase in investment by top players in research and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth.Newer drugs are being developed by companies to offer incremental health benefits.
Changing lifestyle of people across the globe and adoption of sedentary living habits are primary reasons responsible for the increase in the number of chronic diseases that require drugs and therapies for treatment.
According to the FDA, in the year 2014, 41 novel drugs were approved and 45 in the consequent year.
This has also been contributing to growth.Immense funding has been witnessed in the pharmaceutical and biotechnology industries in the recent years.
